FDA approves a Jazz Pharmaceuticals NDA for Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution for treating idiopathic hypersomn...
FDA places a clinical hold on Bluebird Bios Lenti-D (elivaldogene autotemcel) after the company reported a suspected unexpected serious adverse reacti...
Federal Register notice: FDA solicits comments on several issues related to FDAs post-approval regulation of certain drug products approved in abbrevi...
Baxter Healthcare recalls its Dose IQ Safety Software used with the Spectrum IQ Infusion System due to a software defect.
FDA grants a breakthrough therapy designation to Shanghai Junshi Biosciences and Coherus BioSciences for toripalimab in combination with chemotherapy ...
The Cato Institute says if FDA wont resolve its conflicting stance over off-label use and promotion, the courts should do so.
Vifor asks FDA to take specific steps to stay actions the agency took in a 2020 citizen petition response purporting to change the established names a...
Federal Register notice: FDA seeks consumer organizations interested in participating in the selection of voting and nonvoting consumer representative...